4.7 Review

The design of guanidinium-rich transporters and their internalization mechanisms

Journal

ADVANCED DRUG DELIVERY REVIEWS
Volume 60, Issue 4-5, Pages 452-472

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.addr.2007.10.016

Keywords

molecular transporters; cell-penetrating peptides; oligoarginine; bidentate hydrogen bond; endocytosis; adaptive translocation; HIV tat; dendrimers; drug delivery

Funding

  1. NCI NIH HHS [R01 CA031841-27, R37 CA031845, R37 CA031845-27, R01 CA031841] Funding Source: Medline
  2. NATIONAL CANCER INSTITUTE [R01CA031841, R37CA031845] Funding Source: NIH RePORTER

Ask authors/readers for more resources

The ability of a drug or probe to cross a biological barrier has historically been viewed to be a function of its intrinsic physical properties. This view has largely restricted drug design and selection to agents within a narrow log P range. Molecular transporters offer a strategy to circumvent these restrictions. In the case of guanidinium-rich transporters (GRTs), a typically highly water-soluble conjugate is found to readily pass through the non-polar membrane of a cell and for some across tissue barriers. This activity opens a field of opportunities for the use of GRTs to enable delivery of polar and non-polar drugs or probes as well as to enhance uptake of those of intermediate polarity. The field of transporter enabled or enhanced uptake has grown dramatically in the last decade. Some GRT drug conjugates have been advanced into clinical trials. This review will provide an overview of recent work pertinent to the design and mechanism of uptake of GRTs. (C) 2007 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available